Fatal brain damage after dental anaesthesia. Its nature, etiology, and prevention.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 4162291)

Published in Lancet on October 22, 1966

Authors

J B Brierley, A A Miller

Articles by these authors

(truncated to the top 100)

Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol (1982) 5.58

The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol (1981) 5.33

The effects of systemic hypotension upon the human brain. Clinical and neuropathological observations in 11 cases. Brain (1966) 3.92

A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke (1979) 3.78

The lymphatic drainage of the spinal nerve roots in the rabbit. J Anat (1948) 3.49

The nature and time course of the neuronal alterations resulting from oligaemia and hypoglycaemia in the brain of Macaca mulatta. Brain Res (1971) 2.60

Neocortical death after cardiac arrest. A clinical, neurophysiological, and neuropathological report of two cases. Lancet (1971) 2.52

Supernova 2007bi as a pair-instability explosion. Nature (2009) 1.82

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia (1986) 1.82

Anoxic-ischaemic cell change in rat brain light microscopic and fine-structural observations. J Neurol Sci (1972) 1.81

The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope. Br J Exp Pathol (1968) 1.78

Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol (1973) 1.76

A combined light and electron microscope study of early anoxic-ischaemic cell change in rat brain. Brain Res (1970) 1.73

Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol (1973) 1.65

The threshold and neuropathology of cerebral "anoxic-ischemic" cell change. Arch Neurol (1973) 1.57

Atypical teratomas of the pineal and hypothalamus. J Pathol Bacteriol (1966) 1.54

Proceedings: Combined EEG recording and intraventricular administration of drugs in the conscious rat. Br J Pharmacol (1975) 1.48

Brain damage in the rhesus monkey resulting from profound arterial hypotension. I. Its nature, distribution and general physiological correlates. Brain Res (1969) 1.46

Etoposide: an update. Clin Pharm (1989) 1.41

A technique allowing e.e.g. and activity recording together with intraventricular administration of drugs in the conscious rabbit. Br J Pharmacol (1973) 1.39

Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol (2009) 1.36

Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia (1986) 1.35

Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism. Brain (1978) 1.29

Effect of a potent synthetic opioid pentapeptide in some anti-nociceptive and behavioural tests in mice and rats [proceedings]. Br J Pharmacol (1977) 1.28

Features of trisomy 18 and 18p- syndromes in an infant with 45,XY,i(18q). Clin Genet (1979) 1.27

Selective chromatolysis of neurons in the gerbil brain: a possible consequence of "epileptic" activity produced by common carotid artery occlusion. Ann Neurol (1979) 1.27

The earliest alterations in rat neurones and astrocytes after anoxia-ischaemia. Acta Neuropathol (1973) 1.20

Ischaemic brain damage in the gerbil in the absence of 'no-reflow'. J Neurol Neurosurg Psychiatry (1975) 1.16

The effects of profound systemic hypotension upon the brain of M. rhesus: physiological and pathological observations. Brain (1966) 1.15

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol (2005) 1.15

Evidence for early anoxic-ischaemic cell damage in the rat brain. Experientia (1966) 1.13

Neuropathological correlates of neurological impairment following prolonged decompression. Aerosp Med (1969) 1.11

Psychological considerations in dentistry. J Am Dent Assoc (1970) 1.10

Some behavioural and anticonvulsant actions in mice of ethanolamine O-sulphate, an inhibitor of 4-aminobutyrate aminotransferase. Br J Pharmacol (1973) 1.07

Proceedings: Proconvulsant action of folic acid. Br J Pharmacol (1975) 1.07

Behavioural and neurological disturbances associated with hypoxic brain damage. J Neurol Sci (1973) 1.07

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol (1985) 1.06

Cyanide intoxication in Macaca mulatta. Physiological and neuropathological aspects. J Neurol Sci (1977) 1.05

The origin of lipid phagocytes in the central nervous system: I. The intrinsic microglia. J Comp Neurol (1982) 1.04

The origin of lipid phagocytes in the central nervous system: II. The adventitia of blood vessels. J Comp Neurol (1982) 1.02

Antagonism by folic acid of presynaptic inhibition in the rat cuneate nucleus. Br J Pharmacol (1974) 0.99

Communications between vertebro-basilar and carotid arterial circulations in the gerbil. Exp Neurol (1974) 0.98

Brief hypoxia-ischemia initially damages cerebral neurons. Arch Neurol (1975) 0.98

Comparative studies on the effects of metoclopramide and some known neuroleptics on the EEG of the conscious rat [proceedings]. Br J Pharmacol (1976) 0.96

Legionnaires' disease in Vermont, May to October 1977. JAMA (1978) 0.96

Cyanide intoxication in the rat: physiological and neuropathological aspects. J Neurol Neurosurg Psychiatry (1976) 0.95

Miller-Dieker syndrome. Detection of a cryptic chromosome translocation using in situ hybridization in a family with multiple affected offspring. Am J Dis Child (1993) 0.94

Graded hypoxia-oligemia in rat brain. II. Neuropathological alterations and their implications. Arch Neurol (1973) 0.94

Some studies on the convulsant action of folic acid. Br J Pharmacol (1973) 0.93

Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth (1987) 0.93

Delayed pentobarbital administration limits ischemic brain damage in gerbils. Ann Neurol (1979) 0.92

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia (1986) 0.92

Epileptic brain damage in adolescent baboons following seizures induced by allylgycine. Brain (1974) 0.91

Some morphine-like properties of a potent antinociceptive synthetic pentapeptide in relation to physical dependence in rodents [proceedings]. Br J Pharmacol (1977) 0.91

Glial differentiation does not require a neural ground state. Development (1998) 0.89

Remarks on the papers by C.-D. Agardh et al./H. Kalimo et al. "hypoglycemic brain injury, I, II". Acta Neuropathol (1981) 0.89

Malignant meningioma with extracranial metastases and seeding of the subarachnoid space and the ventricles. Pathol Eur (1972) 0.88

The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res (2002) 0.87

Some behavioural and EEG studies on the behavioural depression induced in the rat by ethanolamine O-sulphate, an inhibitor of GABA-transaminase [proceedings]. Br J Pharmacol (1976) 0.87

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. Cancer (1994) 0.87

A behavioral and neuropathological study of the sequelae of profound hypoxia. Brain Res (1970) 0.86

Ischemic necrosis along brain arterial boundary zones: some aspects of its etiology. Adv Neurol (1979) 0.86

The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol (1970) 0.86

The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings]. Br J Pharmacol (1979) 0.85

Brain damage complicating open-heart surgery: a neuropathological study of 46 patients. Proc R Soc Med (1967) 0.85

Cystic fibrosis presenting with anemia and hypoproteinemia in identical twins. Pediatrics (1977) 0.85

Columnar alterations of NADH fluorescence during hypoxia-ischemia in immature rat brain. J Cereb Blood Flow Metab (1982) 0.84

Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes. Blood (1991) 0.84

Neurological study of simulated decompression in supersonic transport aircraft. Aerosp Med (1969) 0.83

Physiological observations during prolonged epileptic seizures in primates and their relation to subsequent brain damage. J Physiol (1972) 0.83

Neuronal loss and gliosis in the hippocampus following repetitive epileptic seizures induced in adolescent baboons by allylglycine. Brain Res (1972) 0.83

Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels. Mol Psychiatry (2012) 0.81

Energy metabolism and histology in the brain during combined hypoxemia and ischemia. Eur Neurol (1972) 0.81

Brain damage due to trimethyltin compounds. Lancet (1981) 0.81

Improved insulin stability through amino acid substitution. Protein Eng (1992) 0.81

The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2010) 0.81

Brain damage in the rhesus monkey resulting from profound arterial hypotension. II. Changes in the spontaneous and evoked electrical activity of the neocortex. Brain Res (1969) 0.81

Acute necrotic myelitis and perivenous encephalomyelitis associated with hypertension and renal infection. J Clin Pathol (1967) 0.80

Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats. Br J Pharmacol (2008) 0.80

A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. Clin Pharmacol Ther (1995) 0.80

Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin. Cancer Res (1987) 0.79

Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel. J Clin Oncol (1996) 0.79

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study. J Clin Oncol (1995) 0.79

The pathogenesis of ischaemic neuronal damage along the cerebral arterial boundary zones in Papio anubis. Brain (1980) 0.79

Comparison between effects of profound arterial hypotension, hypoxia, and cyanide on the brain of Macaca mulatta. Adv Neurol (1975) 0.79

Systemic hypotension-neurological and neuropathological aspects. Mod Trends Neurol (1970) 0.78

Glass-transition temperature of water. Science (1969) 0.78

E.E.G. monitoring for the control of anaesthesia produced by the infusion of althesin in primates. Br J Anaesth (1978) 0.78

Effect of cortical kindling on [3H]D-aspartate uptake and glutamate metabolism in rats. Epilepsy Res (1987) 0.77

Changes in cortical amino acids during electrical kindling in rats. Neuropharmacology (1985) 0.77

Hippocampal lesions produced by prolonged seizures in paralyzed artificially ventilated baboons. Experientia (1973) 0.77

Experimental hypoxic brain damage. J Clin Pathol Suppl (R Coll Pathol) (1977) 0.77

Non-random patterns of host use by the different parasite species exploiting a cockle population. Parasitology (2000) 0.77

Four models for studying cerebral lesions secondary to epileptic seizures. Adv Neurol (1975) 0.76

Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics (1979) 0.76

High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen. Cancer (1989) 0.76

Initial suppression of the locomotor stimulant response to dexamphetamine in rats exposed to a novel environment. Br J Pharmacol (1970) 0.76

The effect of lamotrigine upon development of cortical kindled seizures in the rat. Neuropharmacology (1991) 0.76

Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer. Cancer Treat Rep (1986) 0.76

A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer. Semin Oncol (1997) 0.75